Who misuses sedatives to sleep? A US survey finds two different populations, not one
An analysis of nearly 139,000 Americans finds sedative misuse for sleep clusters among both the socially advantaged and the chronically unwell — pointing to two distinct drivers behind the same behavior.
Sedative misuse for sleep — taking a sedative medication without a prescription, or differently than prescribed, specifically to fall or stay asleep — has been studied mostly as a subset of general prescription drug misuse. A study published this month in Sleep Medicine isolates it as its own behavior and finds it doesn't follow the pattern that dominant narratives about drug misuse would predict [s1].
The data
Researchers analyzed the 2021–2023 National Survey on Drug Use and Health, a US federal survey, covering 138,787 adults aged 18 and older [s1]. Using survey-weighted multinomial logistic regression, they estimated how common sedative misuse for sleep is and which sociodemographic and health factors were associated with it [s1].
What they found
An estimated 0.27% of US adults reported misusing sedatives specifically for sleep — a small share of the population, but one the authors translate to roughly 681,000 Americans given the size of the US adult population [s1].
The demographic pattern split in two directions rather than one. Sedative misuse for sleep was significantly more common among adults with higher income, more education, and non-Hispanic white adults — a pattern the authors associate with greater healthcare access, since prescription sedatives generally require a prescription to misuse in the first place [s1]. At the same time, misuse was also elevated among people attracted to the same sex, people with a history of incarceration, and people with chronic health conditions and poor mental health — groups that tend to carry disproportionate health burdens rather than healthcare access advantages [s1].
Two mechanisms, not one
The authors interpret this as evidence of two distinct processes operating simultaneously rather than a single risk profile: access-driven misuse among people with more contact with the healthcare system and more prescriptions to divert or misuse, and need-driven misuse among people with greater underlying sleep-related health burdens who may be self-managing symptoms outside clinical channels [s1]. The paper argues that public health and clinical attention to sedative misuse has traditionally focused on socially vulnerable groups, and that this pattern suggests attention should extend to socially advantaged groups with high healthcare access as well [s1].
Reading the numbers
A 0.27% prevalence estimate, applied to a population of roughly 260 million US adults, is how the study arrives at approximately 681,000 people [s1] — the paper does not report a separate margin of error for that population-scale estimate, and self-reported survey data on drug misuse is subject to underreporting, meaning the true figure could be higher. The survey measures misuse, not necessarily disordered or harmful use, and doesn't identify which sedative medications were involved, doses, or frequency. This is cross-sectional survey data, meaning it can describe who is more likely to report the behavior but cannot establish why, or which comes first — the health burden or the misuse.
What to watch
Whether the pattern replicates in more recent survey waves, and whether follow-up work can identify which specific sedative classes are involved and at what frequency — details the underlying NSDUH data likely permits but this analysis did not report. This article is not medical advice.
Sources
- Who misuses sedatives for sleep? Evidence from a nationally representative US sample — Sleep Medicine, 9 March 2026
Sources
- Who misuses sedatives for sleep? Evidence from a nationally representative US sample — Sleep Medicine , March 9, 2026
More on
Tuning daytime and evening light did not improve older adults' sleep
In a 12-person crossover trial, blue-enriched daytime light with reduced evening blue did not cut time spent awake at night, though it nudged a brainwave marker of sleep.
Light alone barely moved young adults' clocks; a combined package did
Two small pilot studies in 18-to-25-year-olds found morning bright light on its own shifted circadian timing little, while adding a timed schedule and evening blue-blockers advanced it about 35 minutes.
Alcohol disrupts REM sleep from about two drinks. It only speeds sleep onset at five.
A meta-analysis of 27 studies found a dose-response pattern that runs against the nightcap logic: the sedative effect needs a high dose, and the REM disruption starts at a low one.
Waking in the night is the norm. Struggling to get back to sleep is not.
About a third of adults on two continents wake at least three nights a week. The 7.7% who cannot resume sleep carry almost all of the daytime damage — and the cause is often not what the sleeper thinks.